Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method

被引:10
|
作者
Manduru, M
Mihm, LB
White, RL
Friedrich, LV
Flume, PA
Bosso, JA
机构
[1] MED UNIV S CAROLINA,COLL PHARM,QF 218,ANTIINFECT RES LAB,CHARLESTON,SC 29425
[2] MED UNIV S CAROLINA,COLL MED,DEPT MED,CHARLESTON,SC 29425
[3] MED UNIV S CAROLINA,COLL MED,DEPT PEDIAT,CHARLESTON,SC 29425
关键词
D O I
10.1128/AAC.41.11.2527
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bactericidal activity, historically assessed by in vitro tests which employ fixed drug concentrations, may also be evaluated in in vitro pharmacodynamic models in which in vivo pharmacokinetics and bacterial growth conditions can be simulated, However, systematic comparisons between the two methods are lacking, We evaluated the bactericidal activities of ceftazidime, at two different concentration/MIC ratios (C/MICs), against 10 clinical isolates of Pseudomonas aeruginosa in a two-compartment model with continuous-infusion conditions and a 2-h half-life. These values were compared to those determined by traditional 24-h time-kill (TTK) methods at the same C/MICs, Bactericidal activities were compared by using area under the colony count-time curves, Antibiotic exposure (area under the drug concentration-time curve) was also evaluated, Although bactericidal activity appeared greater by the TTK method (P = 0.05), when it was normalized for drug exposure, these differences disappeared (P = 0.2), This disparity was likely due to differences in drug exposure in the TTK method and in the peripheral compartment of the model (site of bacteria) over the first 8 h of the experiment, during which the antibiotic accumulated to target concentrations, This suggests that the bactericidal effects with constant antibiotic concentrations are similar in the two methods; however, this may not hold true with fluctuating drug concentrations, Further, results from the pharmacodynamic model may theoretically be more relevant, as in vivo pharmacokinetics and bacterial growth conditions can be more faithfully simulated.
引用
收藏
页码:2527 / 2532
页数:6
相关论文
共 50 条
  • [31] Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patients
    Rolston, Kenneth V. I.
    Wang, Weiqun
    Nesher, Lior
    Smith, Jordan R.
    Rybak, Michael J.
    Prince, Randall A.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 87 (04) : 338 - 342
  • [32] Evaluation of the in vitro interaction of fosfomycin and meropenem against metallo-β-lactamase-producing Pseudomonas aeruginosa using Etest and time-kill assay
    Jahan, Sanjida
    Davis, Heather
    Ashcraft, Deborah S.
    Pankey, George A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 371 - 376
  • [33] In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves
    Li, Yan
    Sun, Shujuan
    Guo, Qiongjie
    Ma, Lin
    Shi, Changwen
    Su, Lequn
    Li, Hongjian
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 577 - 585
  • [34] In vitro activity of ceftazidime/avibactam against isolates of Pseudomonas aeruginosa collected in European countries: INFORM global surveillance 2012-15
    Kazmierczak, Krystyna M.
    de Jonge, Boudewijn L. M.
    Stone, Gregory G.
    Sahm, Daniel F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (10) : 2777 - 2781
  • [35] Doripenem versus Pseudomonas aeruginosa in vitro:: Activity against characterized isolates, mutants, and transconjugants and resistance selection potential
    Mushtaq, S
    Ge, YG
    Livermore, DM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) : 3086 - 3092
  • [36] In Vitro Activity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from US Medical Centers by Census Region, 2014
    Huband, Michael D.
    Castanheira, Mariana
    Flamm, Robert K.
    Farrell, David J.
    Jones, Ronald N.
    Sader, Helio S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (04) : 2537 - 2541
  • [37] Comment on: Elucidation of the pharmacokinetic/pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model
    Plant, Aiden J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (11) : 3216 - 3217
  • [38] Comparative in vitro antipseudomonal activity of ceftolozane/tazobactam against Pseudomonas aeruginosa isolates from children with cystic fibrosis
    Kanwar, Neena
    Harrison, Christopher J.
    Pence, Morgan A.
    Qin, Xuan
    Selvarangan, Rangaraj
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2023, 105 (04)
  • [39] Evaluation of the in vitro activity of amphotericin B by time-kill curve methodology against large and small capsulate C. neoformans isolates
    Cordoba, Susana
    Afeltra, Javier
    Vitale, Roxana G.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 71 (03) : 260 - 262
  • [40] A Time-Kill Assay Study on the Synergistic Bactericidal Activity of Pomegranate Rind Extract and Zn (II) against Methicillin-Resistant Staphylococcus aureus (MRSA), Staphylococcus epidermidis, Escherichia coli, and Pseudomonas aeruginosa
    Alrashidi, Amal
    Jafar, Mohammed
    Higgins, Niamh
    Mulligan, Ciara
    Varricchio, Carmine
    Moseley, Ryan
    Celiksoy, Vildan
    Houston, David M. J.
    Heard, Charles M.
    BIOMOLECULES, 2021, 11 (12)